NHS-muIL12 also induced the in vivo activation of splenic NK cells (Figure 4C), tumor-infiltrating NK cells (Figure 4D), and splenic CD8+ T cells (Figure 4E) in MC38 tumor-bearing mice. This evidence concerns the gene CD8A and neoplasm.